|
VPS37C expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.41309999996042E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.991040E-04 |
| Normal-vs-Stage2 |
8.39779999983747E-07 |
| Normal-vs-Stage3 |
3.74210000000375E-05 |
| Normal-vs-Stage4 |
8.44170000000588E-05 |
| Stage1-vs-Stage2 |
1.802020E-02 |
| Stage1-vs-Stage3 |
1.924240E-01 |
| Stage1-vs-Stage4 |
2.212200E-01 |
| Stage2-vs-Stage3 |
2.104200E-01 |
| Stage2-vs-Stage4 |
3.213800E-01 |
| Stage3-vs-Stage4 |
8.441800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.85266999999101E-05 |
| Normal-vs-AfricanAmerican |
2.078500E-02 |
| Normal-vs-Asian |
2.987700E-02 |
| Caucasian-vs-AfricanAmerican |
5.722600E-01 |
| Caucasian-vs-Asian |
1.395570E-01 |
| AfricanAmerican-vs-Asian |
6.166800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.01629999996289E-06 |
| Normal-vs-Female |
3.6847000000062E-05 |
| Male-vs-Female |
6.864500E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.343240E-03 |
| Normal-vs-Age(41-60Yrs) |
1.53548999999309E-05 |
| Normal-vs-Age(61-80Yrs) |
2.67230000017271E-07 |
| Normal-vs-Age(81-100Yrs) |
2.178400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.359800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.403700E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.016200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.724810E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.427000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.734200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.580400E-02 |
| Classical-VS-Follicular |
1.63900000238471E-08 |
| Classical-VS-Other |
9.434800E-01 |
| Classical-VS-Normal |
1.238870E-03 |
| Tall-VS-Follicular |
1.547900E-02 |
| Tall-VS-Other |
5.897600E-01 |
| Tall-VS-Normal |
1.240550E-04 |
| Follicular-VS-Other |
7.431900E-02 |
| Follicular-VS-Normal |
4.90130047658965E-10 |
| Other-VS-Normal |
2.848200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.81359999970898E-07 |
| Normal-vs-N1 |
6.193800E-04 |
| N0-vs-N1 |
5.453600E-01 |
|
|
